Home HIV FAQ My Amedeo About Flying Publisher   

Amedeo Prize 2008
The 21 Finalists


  HIV Infection

  Free Subscription


Articles published in J Acquir Immune Defic Syndr

Retrieve available abstracts of 376 articles:
HTML format

Single Articles


    May 2008
  1. HAMERS RL , de Beer IH, Kaura H, van Vugt M, et al
    Diagnostic Accuracy of 2 Oral Fluid-Based Tests for HIV Surveillance in Namibia.
    J Acquir Immune Defic Syndr. 2008;48:116-118.
    PubMed     Related articles   


  2. DILLEY JW , Loeb L, Marson K, Chen S, et al
    Sexual Compulsiveness and Change in Unprotected Anal Intercourse: Unexpected Results From a Randomized Controlled HIV Counseling Intervention Study.
    J Acquir Immune Defic Syndr. 2008;48:113-114.
    PubMed     Related articles   


    April 2008
  3. BARONCELLI S , Andreotti M, Guidotti G, Pirillo MF, et al
    Tumor Necrosis Factor-alpha, Interleukin-10, and alpha-Defensins in Plasma and Breast Milk of HIV-Infected Highly Active Antiretroviral Therapy-Treated and Untreated Pregnant Women in Mozambique.
    J Acquir Immune Defic Syndr. 2008;47:647-649.
    PubMed     Related articles   


  4. NWENEKA CV
    Delayed Recognition of HIV Infection in Malnourished Children Is Associated With Poor Clinical Outcome in Low HIV Prevalence Settings: Preliminary Observations.
    J Acquir Immune Defic Syndr. 2008;47:645-7.
    PubMed     Related articles   


  5. MCKELLAR MS , Jongthavorn P, Khanlou H
    False-Positivity of HIV-2 Immunoblots in a Cohort of Elite Suppressors Infected With HIV-1.
    J Acquir Immune Defic Syndr. 2008;47:644.
    PubMed     Related articles   


  6. NYUNT MM , Becker S, Macfarland RT, Chee P, et al
    Pharmacokinetic Effect of AMD070, an Oral CXCR4 Antagonist, on CYP3A4 and CYP2D6 Substrates Midazolam and Dextromethorphan in Healthy Volunteers.
    J Acquir Immune Defic Syndr. 2008;47:559-565.
    PubMed     Related articles    Abstract available


  7. SINCLAIR E , Ronquillo R, Lollo N, Deeks SG, et al
    Antiretroviral Treatment Effect on Immune Activation Reduces Cerebrospinal Fluid HIV-1 Infection.
    J Acquir Immune Defic Syndr. 2008;47:544-552.
    PubMed     Related articles    Abstract available


  8. KESSLER JA , Ponce P, Saleshando G, Gluckman S, et al
    Risk Factors for Failure to Be Offered Routine HIV Testing Among Adult Medical Inpatients in Botswana.
    J Acquir Immune Defic Syndr. 2008;47:525-526.
    PubMed     Related articles   


  9. DACHRAOUI R , Depatureaux A, Chakroun M, Fodha I, et al
    Monitoring of HIV-1 Resistance in Tunisia (North Africa) With a Dried Plasma Spot Strategy.
    J Acquir Immune Defic Syndr. 2008;47:522-525.
    PubMed     Related articles   


  10. ELFORD J , Ibrahim F, Bukutu C, Anderson J, et al
    Disclosure of HIV Status: The Role of Ethnicity Among People Living With HIV in London.
    J Acquir Immune Defic Syndr. 2008;47:514-521.
    PubMed     Related articles    Abstract available


  11. BRAHMBHATT H , Sullivan D, Kigozi G, Askin F, et al
    Association of HIV and Malaria With Mother-to-Child Transmission, Birth Outcomes, and Child Mortality.
    J Acquir Immune Defic Syndr. 2008;47:472-476.
    PubMed     Related articles    Abstract available


  12. PREAU M , Leport C, Villes V, Michelet C, et al
    Prevalence and predictors of deterioration of a trustful patient-provider relationship among HIV-infected persons treated with antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2008;47:467-71.
    PubMed     Related articles    Abstract available


  13. BERENGUER J , Miralles P, Ribera JM, Rubio R, et al
    Characteristics and outcome of AIDS-related Hodgkin lymphoma before and after the introduction of highly active antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2008;47:422-8.
    PubMed     Related articles    Abstract available


    March 2008
  14. MAURER K , Harrer EG, Goldwich A, Eismann K, et al
    Role of Cytotoxic T-Lymphocyte-Mediated Immune Selection in a Dominant Human Leukocyte Antigen-B8-Restricted Cytotoxic T-Lymphocyte Epitope in Nef.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  15. HENDRICKSON SL , Jacobson LP, Nelson GW, Phair JP, et al
    Host Genetic Influences on Highly Active Antiretroviral Therapy Efficacy and AIDS-Free Survival.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  16. DJOMAND G , Metch B, Zorrilla CD, Donastorg Y, et al
    The HVTN Protocol 903 Vaccine Preparedness Study: Lessons Learned in Preparation for HIV Vaccine Efficacy Trials.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  17. WOHL D , Scherzer R, Heymsfield S, Simberkoff M, et al
    The Associations of Regional Adipose Tissue With Lipid and Lipoprotein Levels in HIV-Infected Men.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  18. WINTERS B , Montaner J, Harrigan PR, Gazzard B, et al
    Determination of Clinically Relevant Cutoffs for HIV-1 Phenotypic Resistance Estimates Through a Combined Analysis of Clinical Trial and Cohort Data.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  19. SHEPARD BD , Loutfy MR, Raboud J, Mandy F, et al
    Early Changes in T-Cell Activation Predict Antiretroviral Success in Salvage Therapy of HIV Infection.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  20. DUMOND JB , Reddy YS, Troiani L, Rodriguez JF, et al
    Differential Extracellular and Intracellular Concentrations of Zidovudine and Lamivudine in Semen and Plasma of HIV-1-Infected Men.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  21. PALMISANO L , Giuliano M, Chiarotti F, Zanchetta M, et al
    Modifications of HIV-1 DNA and Provirus-Infected Cells During 24 Months of Intermittent Highly Active Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  22. SHALEKOFF S , Meddows-Taylor S, Schramm DB, Donninger SL, et al
    Host CCL3L1 Gene Copy Number in Relation to HIV-1-Specific CD4+and CD8+T-Cell Responses and Viral Load in South African Women.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  23. KILEWO C , Karlsson K, Massawe A, Lyamuya E, et al
    Prevention of Mother-to-Child Transmission of HIV-1 Through Breast-Feeding by Treating Infants Prophylactically With Lamivudine in Dar es Salaam, Tanzania: The Mitra Study.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  24. FOX MP , Brooks D, Kuhn L, Aldrovandi G, et al
    Reduced Mortality Associated With Breast-Feeding-Acquired HIV Infection and Breast-Feeding Among HIV-Infected Children in Zambia.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  25. REINGOLD JS , Wanke C, Kotler DP, Lewis CE, et al
    Association of HIV Infection and HIV/HCV Coinfection With C-Reactive Protein Levels: The Fat Redistribution and Metabolic Change in HIV Infection (FRAM) Study.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  26. OPERARIO D , Soma T, Underhill K
    Sex Work and HIV Status Among Transgender Women: Systematic Review and Meta-Analysis.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  27. MASSAD LS , Evans CT, Wilson TE, Golub ET, et al
    Impact of menopause on condom use by HIV-seropositive and comparison seronegative women.
    J Acquir Immune Defic Syndr. 2008;47:401-2.
    PubMed     Related articles   


  28. DIAZ RS , Vasconcelos L, Hayden RL, Tenore S, et al
    Similar efficacy of lopinavir/ritonavir-containing regimens among clades B and F HIV-1-Infected individuals in Brazil.
    J Acquir Immune Defic Syndr. 2008;47:399-401.
    PubMed     Related articles   


  29. MIROCHNICK M , Nielsen-Saines K, Pilotto JH, Pinto J, et al
    Nevirapine concentrations in newborns receiving an extended prophylactic regimen.
    J Acquir Immune Defic Syndr. 2008;47:334-7.
    PubMed     Related articles    Abstract available


  30. SEMRAU K , Ghosh M, Kankasa C, Sinkala M, et al
    Temporal and lateral dynamics of HIV shedding and elevated sodium in breast milk among HIV-positive mothers during the first 4 months of breast-feeding.
    J Acquir Immune Defic Syndr. 2008;47:320-8.
    PubMed     Related articles    Abstract available


  31. BUCHACZ K , Weidle PJ, Moore D, Were W, et al
    Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda.
    J Acquir Immune Defic Syndr. 2008;47:304-11.
    PubMed     Related articles    Abstract available


  32. KISER JJ , Aquilante CL, Anderson PL, King TM, et al
    Clinical and genetic determinants of intracellular tenofovir diphosphate concentrations in HIV-infected patients.
    J Acquir Immune Defic Syndr. 2008;47:298-303.
    PubMed     Related articles    Abstract available


  33. ZEHENDER G , Ebranati E, De Maddalena C, Gianelli E, et al
    Description of a "trans-Saharan" strain of human T-lymphotropic virus type 1 in West Africa.
    J Acquir Immune Defic Syndr. 2008;47:269-73.
    PubMed     Related articles    Abstract available


  34. KAHN J , Des Jarlais CD, Dobkin L, Barrs SF, et al
    Mentoring the next generation of HIV prevention researchers: a model mentoring program at the University of California San Francisco and Gladstone Institute of Immunology and Virology Center for AIDS research.
    J Acquir Immune Defic Syndr. 2008;47 Suppl 1:S5-9.
    PubMed     Related articles    Abstract available


  35. DICLEMENTE RJ , Wingood GM, Blank MB, Metzger DS, et al
    Future directions for HIV prevention research: charting a prevention science research agenda.
    J Acquir Immune Defic Syndr. 2008;47 Suppl 1:S47-8.
    PubMed     Related articles   


  36. WINGOOD GM , DiClemente RJ
    The ADAPT-ITT model: a novel method of adapting evidence-based HIV Interventions.
    J Acquir Immune Defic Syndr. 2008;47 Suppl 1:S40-6.
    PubMed     Related articles    Abstract available


  37. CASSELS S , Clark SJ, Morris M
    Mathematical models for HIV transmission dynamics: tools for social and behavioral science research.
    J Acquir Immune Defic Syndr. 2008;47 Suppl 1:S34-9.
    PubMed     Related articles    Abstract available


  38. KELLY JA , Spielberg F, McAuliffe TL
    Defining, designing, implementing, and evaluating phase 4 HIV prevention effectiveness trials for vulnerable populations.
    J Acquir Immune Defic Syndr. 2008;47 Suppl 1:S28-33.
    PubMed     Related articles    Abstract available


  39. KRAUT-BECHER J , Eisenberg M, Voytek C, Brown T, et al
    Examining racial disparities in HIV: lessons from sexually transmitted infections research.
    J Acquir Immune Defic Syndr. 2008;47 Suppl 1:S20-7.
    PubMed     Related articles    Abstract available


  40. WALKUP J , Blank MB, Gonzalez JS, Safren S, et al
    The impact of mental health and substance abuse factors on HIV prevention and treatment.
    J Acquir Immune Defic Syndr. 2008;47 Suppl 1:S15-9.
    PubMed     Related articles    Abstract available


  41. PINKERTON SD , Pearson CR, Eachus SR, Berg KM, et al
    Proposal for the development of a standardized protocol for assessing the economic costs of HIV prevention interventions.
    J Acquir Immune Defic Syndr. 2008;47 Suppl 1:S10-4.
    PubMed     Related articles    Abstract available


  42. RAFFA JD , Tossonian HK, Grebely J, Petkau AJ, et al
    Intermediate highly active antiretroviral therapy adherence thresholds and empirical models for the development of drug resistance mutations.
    J Acquir Immune Defic Syndr. 2008;47:397-9.
    PubMed     Related articles   


  43. BLANK MB , Metzger DS, Wingood GM, DiClemente RJ, et al
    The first national scientific meeting of the Social and Behavioral Science Research Network.
    J Acquir Immune Defic Syndr. 2008;47 Suppl 1:S1-4.
    PubMed     Related articles   


    February 2008
  44. KIM GJ , Nam JG, Shin BG, Kee MK, et al
    National Survey of Prevalent HIV Strains: Limited Genetic Variation of Korean HIV-1 Clade B Within the Population of Korean Men Who Have Sex With Men.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  45. DUBE S , Boily MC, Mugurungi O, Mahomva A, et al
    Estimating Vertically Acquired HIV Infections and the Impact of the Prevention of Mother-to-Child Transmission Program in Zimbabwe: Insights From Decision Analysis Models.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  46. GORBACH PM , Drumright LN, Javanbakht M, Pond SL, et al
    Antiretroviral Drug Resistance and Risk Behavior Among Recently HIV-Infected Men Who Have Sex With Men.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  47. CRAW JA , Gardner LI, Marks G, Rapp RC, et al
    Brief Strengths-Based Case Management Promotes Entry Into HIV Medical Care: Results of the Antiretroviral Treatment Access Study-II.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  48. TAN R , Westfall AO, Willig JH, Mugavero MJ, et al
    Clinical Outcome of HIV-Infected Antiretroviral-Naive Patients With Discordant Immunologic and Virologic Responses to Highly Active Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  49. MORPETH SC , Thielman NM, Ramadhani HO, Hamilton JD, et al
    Effect of Trimethoprim-Sulfamethoxazole Prophylaxis on Antimicrobial Resistance of Fecal Escherichia coli in HIV-Infected Patients in Tanzania.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  50. TIEN PC , Kotler DP, Overton ET, Lewis CE, et al
    Regional Adipose Tissue and Elevations in Serum Aminotransferases in HIV-Infected Individuals.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  51. SULLIVAN PS , Hanson DL, Brooks JT
    Impact on Hemoglobin of Starting Combination Antiretroviral Therapy With or Without Zidovudine in Anemic HIV-Infected Patients.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  52. VAN SIGHEM A , Zhang S, Reiss P, Gras L, et al
    Immunologic, Virologic, and Clinical Consequences of Episodes of Transient Viremia During Suppressive Combination Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  53. BANGSBERG DR
    The Achilles' Heel of HIV Treatment in Resource-Limited Settings.
    J Acquir Immune Defic Syndr. 2008;47:266-7.
    PubMed     Related articles   


  54. SIEDNER MJ , Atta MG, Lucas GM, Perazella MA, et al
    Poor Validity of Urine Dipstick as a Screening Tool for Proteinuria in HIV-Positive Patients.
    J Acquir Immune Defic Syndr. 2008;47:261-263.
    PubMed     Related articles   


  55. MEYBECK A , Fortin C, Ruimy R, Joly V, et al
    Active Tuberculosis Does Not Always Imply the Initiation of Highly Active Antiretroviral Therapy in HIV-Infected Patients.
    J Acquir Immune Defic Syndr. 2008;47:259-261.
    PubMed     Related articles   


  56. BONGIOVANNI M , Ranieri R, Casana M, Tordato F, et al
    Insulin Resistance Affects Early Virologic Response in HIV-Infected Subjects Treated for Hepatitis C Infection.
    J Acquir Immune Defic Syndr. 2008;47:258-259.
    PubMed     Related articles   


  57. SMIT C , van den Berg C, Geskus R, Berkhout B, et al
    Risk of Hepatitis-Related Mortality Increased Among Hepatitis C Virus/HIV-Coinfected Drug Users Compared With Drug Users Infected Only With Hepatitis C Virus: A 20-Year Prospective Study.
    J Acquir Immune Defic Syndr. 2008;47:221-225.
    PubMed     Related articles    Abstract available


  58. LEWIN SR , Murray JM, Solomon A, Wightman F, et al
    Virologic determinants of success after structured treatment interruptions of antiretrovirals in acute HIV-1 infection.
    J Acquir Immune Defic Syndr. 2008;47:140-47.
    PubMed     Related articles    Abstract available


  59. JAEN A , Esteve A, Miro JM, Tural C, et al
    Determinants of HIV progression and assessment of the optimal time to initiate highly active antiretroviral therapy: PISCIS Cohort (Spain).
    J Acquir Immune Defic Syndr. 2008;47:212-20.
    PubMed     Related articles    Abstract available


  60. SINHA G , Dyalchand A, Khale M, Kulkarni G, et al
    Low utilization of HIV testing during pregnancy: What are the barriers to HIV testing for women in rural India?
    J Acquir Immune Defic Syndr. 2008;47:248-52.
    PubMed     Related articles    Abstract available


  61. LIU AY , Kittredge PV, Vittinghoff E, Raymond HF, et al
    Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men.
    J Acquir Immune Defic Syndr. 2008;47:241-7.
    PubMed     Related articles    Abstract available


  62. BUCHACZ K , Klausner JD, Kerndt PR, Shouse RL, et al
    HIV incidence among men diagnosed with early syphilis in Atlanta, San Francisco, and Los Angeles, 2004 to 2005.
    J Acquir Immune Defic Syndr. 2008;47:234-40.
    PubMed     Related articles    Abstract available


  63. HELLINGER F
    Practice makes perfect: a volume-outcome study of hospital patients with HIV disease.
    J Acquir Immune Defic Syndr. 2008;47:226-33.
    PubMed     Related articles    Abstract available


  64. CHESSON HW , Gift TL
    Decreases in AIDS mortality and increases in primary and secondary syphilis in men who have sex with men in the United States.
    J Acquir Immune Defic Syndr. 2008;47:263-4.
    PubMed     Related articles   


  65. PETTY CS , Tompkins MB, Tompkins WA
    Transforming growth factor-beta/transforming growth factor-betaRII signaling may regulate CD4+CD25+ T-regulatory cell homeostasis and suppressor function in feline AIDS lentivirus infection.
    J Acquir Immune Defic Syndr. 2008;47:148-60.
    PubMed     Related articles    Abstract available


    January 2008
  66. DILLON SM , Robertson KB, Pan SC, Mawhinney S, et al
    Plasmacytoid and Myeloid Dendritic Cells With a Partial Activation Phenotype Accumulate in Lymphoid Tissue During Asymptomatic Chronic HIV-1 Infection.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  67. BOURGEOIS N , Lachaud L, Reynes J, Rouanet I, et al
    Long-Term Monitoring of Visceral Leishmaniasis in Patients With AIDS: Relapse Risk Factors, Value of Polymerase Chain Reaction, and Potential Impact on Secondary Prophylaxis.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  68. LURIE M , Pronyk P, de Moor E, Heyer A, et al
    Sexual Behavior and Reproductive Health Among HIV-Infected Patients in Urban and Rural South Africa.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  69. TASSIOPOULOS K , Williams PL, Seage GR 3rd, Crain M, et al
    Association of Hypercholesterolemia Incidence With Antiretroviral Treatment, Including Protease Inhibitors, Among Perinatally HIV-Infected Children.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  70. HUANG Y , Chen Z, Zhang W, Gurner D, et al
    Design, Construction, and Characterization.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  71. CHEN Z , Huang Y, Zhao X, Ba L, et al
    Design, Construction, and Characterization of a Multigenic Modified Vaccinia Ankara Candidate Vaccine Against Human Immunodeficiency Virus Type 1 Subtype C/B'
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  72. BENKI S , Mostad SB, Richardson BA, Mandaliya K, et al
    Increased Levels of HIV-1-Infected Cells in Endocervical Secretions After the Luteinizing Hormone Surge.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  73. PLATT L , Rhodes T, Hickman M, Mikhailova L, et al
    Changes in HIV Prevalence and Risk Among New Injecting Drug Users in a Russian City of High HIV Prevalence.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  74. SCOTT KC , Philip S, Ahrens K, Kent CK, et al
    High Prevalence of Gonococcal and Chlamydial Infection in Men Who Have Sex With Men With Newly Diagnosed HIV Infection: An Opportunity for Same-Day Presumptive Treatment.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  75. CARLUCCI JG , Kamanga A, Sheneberger R, Shepherd BE, et al
    Predictors of Adherence to Antiretroviral Therapy in Rural Zambia.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  76. HOFFMAN IF , Martinson FE, Powers KA, Chilongozi DA, et al
    The Year-Long Effect of HIV-Positive Test Results on Pregnancy Intentions, Contraceptive Use, and Pregnancy Incidence Among Malawian Women.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  77. CHONG H , Hong K, Zhang C, Nie J, et al
    Genetic and Neutralization Properties of HIV-1 env Clones From Subtype B/BC/AE Infections in China.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  78. WICHUKCHINDA N , Nakayama EE, Rojanawiwat A, Pathipvanich P, et al
    Effects of CCR2 and CCR5 Polymorphisms on HIV-1 Infection in Thai Females.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  79. BRAIBANT M , Agut H, Rouzioux C, Costagliola D, et al
    Characteristics of the env Genes of HIV Type 1 Quasispecies in Long-Term Nonprogressors With Broadly Neutralizing Antibodies.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  80. JUSTMAN JE , Hoover DR, Shi Q, Tan T, et al
    Longitudinal Anthropometric Patterns Among HIV-Infected and HIV-Uninfected Women.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  81. VOURVAHIS M , Tappouni HL, Patterson KB, Chen YC, et al
    The Pharmacokinetics and Viral Activity of Tenofovir in the Male Genital Tract.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  82. AHONKHAI AA , Gebo KA, Streiff MB, Moore RD, et al
    Venous Thromboembolism in Patients With HIV/AIDS: A Case-Control Study.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  83. CACHAY ER , Frost SD, Poon AF, Looney D, et al
    Herpes Simplex Virus Type 2 Acquisition During Recent HIV Infection Does Not Influence Plasma HIV Levels.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  84. WEAVER MR , Conover CJ, Proescholdbell RJ, Arno PS, et al
    Utilization of Mental Health and Substance Abuse Care for People Living With HIV/AIDS, Chronic Mental Illness, and Substance Abuse Disorders.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  85. REN Y , Nuttall JJ, Egbers C, Eley BS, et al
    Effect of Rifampicin on Lopinavir Pharmacokinetics in HIV-Infected Children With Tuberculosis.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  86. SOLAS C , Colson P, Ravaux I, Poizot-Martin I, et al
    The Genotypic Inhibitory Quotient: A Predictive Factor of Atazanavir Response in HIV-1-Infected Treatment-Experienced Patients.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  87. CURRIER J , Scherzer R, Bacchetti P, Heymsfield S, et al
    Regional Adipose Tissue and Lipid and Lipoprotein Levels in HIV-Infected Women.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  88. JOY R , Druyts EF, Brandson EK, Lima VD, et al
    Impact of Neighborhood-Level Socioeconomic Status on HIV Disease Progression in a Universal Health Care Setting.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  89. YI Y , Loftin L, Wang L, Ratcliffe SJ, et al
    Entry Coreceptor Use and Fusion Inhibitor T20 Sensitivity.
    J Acquir Immune Defic Syndr. 2008;.
    PubMed     Related articles    Abstract available


  90. RAJ A , Reed E, Santana MC, Welles SL, et al
    History of Incarceration and Gang Involvement Are Associated With Recent Sexually Transmitted Disease/HIV Diagnosis in African American Men.
    J Acquir Immune Defic Syndr. 2008;47:131-134.
    PubMed     Related articles   


  91. GIOVANNA O , Elisabetta T, Rosangela B, Antonella A, et al
    Human Papillomavirus Genotypes and Anal-Related Lesions Among HIV-1-Infected Men in Milan, Italy.
    J Acquir Immune Defic Syndr. 2008;47:129-31.
    PubMed     Related articles   


  92. BERNAL E , Masia M, Padilla S, Hernandez I, et al
    Low Prevalence of Peripheral Arterial Disease in HIV-Infected Patients With Multiple Cardiovascular Risk Factors.
    J Acquir Immune Defic Syndr. 2008;47:126-127.
    PubMed     Related articles   


  93. STIER EA , Goldstone SE, Berry JM, Panther LA, et al
    Infrared Coagulator Treatment of High-Grade Anal Dysplasia in HIV-Infected Individuals: An AIDS Malignancy Consortium Pilot Study.
    J Acquir Immune Defic Syndr. 2008;47:56-61.
    PubMed     Related articles    Abstract available


  94. VALERIO L , Yazdanpanah Y, Poizot-Martin I, Rosenthal E, et al
    Baseline CD4 Cell Count and Outcome of Pegylated Interferon Plus Ribavirin Therapy in HIV/Hepatitis C Virus-Coinfected Patients.
    J Acquir Immune Defic Syndr. 2008;47:50-55.
    PubMed     Related articles    Abstract available


  95. OPRAVIL M , Sasadeusz J, Cooper DA, Rockstroh JK, et al
    Effect of Baseline CD4 Cell Count on the Efficacy and Safety of Peginterferon Alfa-2a (40KD) Plus Ribavirin in Patients With HIV/Hepatitis C Virus Coinfection.
    J Acquir Immune Defic Syndr. 2008;47:36-49.
    PubMed     Related articles    Abstract available


  96. MANOSUTHI W , Sungkanuparph S, Ruxrungtham K, Prasithsirikul W, et al
    Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir.
    J Acquir Immune Defic Syndr. 2008;47:127-9.
    PubMed     Related articles   


  97. LICHTENSTEIN KA , Armon C, Buchacz K, Chmiel JS, et al
    Initiation of antiretroviral therapy at CD4 cell counts >/=350 cells/mm3 does not increase incidence or risk of peripheral neuropathy, anemia, or renal insufficiency.
    J Acquir Immune Defic Syndr. 2008;47:27-35.
    PubMed     Related articles    Abstract available


  98. FALLERT BA , Poveda S, Schaefer TM, Pfeifer ME, et al
    Virologic and immunologic events in hilar lymph nodes during simian immunodeficiency virus infection: development of polarized inflammation.
    J Acquir Immune Defic Syndr. 2008;47:16-26.
    PubMed     Related articles    Abstract available


  99. REYNOLDS NR , Testa MA, Su M, Chesney MA, et al
    Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial.
    J Acquir Immune Defic Syndr. 2008;47:62-8.
    PubMed     Related articles    Abstract available


    December 2007
  100. BOZZETTE SA , Ake CF, Tam HK, Phippard A, et al
    Long-Term Survival and Serious Cardiovascular Events in HIV-Infected Patients Treated With Highly Active Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  101. TEDALDI EM , Absalon J, Thomas AJ, Shlay JC, et al
    Ethnicity, Race, and Gender: Differences in Serious Adverse Events Among Participants in an Antiretroviral Initiation Trial: Results of CPCRA 058 (FIRST Study).
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  102. WALMSLEY SL , Katlama C, Lazzarin A, Aresteh K, et al
    Pharmacokinetics, Safety, and Efficacy of Tipranavir Boosted With Ritonavir Alone or in Combination With Other Boosted Protease Inhibitors as Part of Optimized Combination Antiretroviral Therapy in Highly Treatment-Experienced Patients (BI Study 1182.51)
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  103. KISER JJ , Gerber JG, Predhomme JA, Wolfe P, et al
    Drug/Drug Interaction Between Lopinavir/Ritonavir and Rosuvastatin in Healthy Volunteers.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  104. CHIDZONGA MM , Mwale M, Malvin K, Martin JN, et al
    Oral Candidiasis as a Marker of HIV Disease Progression Among Zimbabwean Women.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  105. GLYNN MK , Ling Q, Phelps R, Li J, et al
    Accurate Monitoring of the HIV Epidemic in the United States: Case Duplication in the National HIV/AIDS Surveillance System.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  106. COCOHOBA J , Wang QJ, Cox C, Gange SJ, et al
    Consistency of Initial Antiretroviral Therapy With HIV Treatment Guidelines in a US Cohort of HIV-Infected Women.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  107. WHITE RG , Orroth KK, Glynn JR, Freeman EE, et al
    Treating Curable Sexually Transmitted Infections to Prevent HIV in Africa: Still an Effective Control Strategy?
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  108. PINKERTON SD , Holtgrave DR, Galletly CL
    Infections Prevented by Increasing HIV Serostatus Awareness in the United States, 2001 to 2004.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  109. MERCHANT RC , Chee KJ, Liu T, Mayer KH, et al
    Incidence of Visits for Health Care Worker Blood or Body.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  110. STRATHDEE SA , Lozada R, Pollini RA, Brouwer KC, et al
    Individual, Social, and Environmental Influences Associated With HIV Infection Among Injection Drug Users in Tijuana, Mexico.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  111. SIKKEMA KJ , Wilson PA, Hansen NB, Kochman A, et al
    Effects of a Coping Intervention on Transmission Risk Behavior Among People Living With HIV/AIDS and a History of Childhood Sexual Abuse.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  112. MAYER KH , Mimiaga MJ, Cohen D, Grasso C, et al
    Tenofovir DF Plus Lamivudine or Emtricitabine for Nonoccupational Postexposure Prophylaxis (NPEP) in a Boston Community Health Center.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  113. TOZZI V , Balestra P, Vlassi C, Salvatori MF, et al
    Author's Response to "Persistence of Neuropsychologic Deficits Despite Long-Term Highly Active Antiretroviral Therapy in Patients With HIV-Related Neurocognitive Impairment".
    J Acquir Immune Defic Syndr. 2007;46:657-8.
    PubMed     Related articles   


  114. GARVEY L , Thomson EC, Main J, Winston A, et al
    Response to "Persistence of Neuropsychologic Deficits Despite Long-Term Highly Active Antiretroviral Therapy in Patients With HIV-Related Neurocognitive Impairment"
    J Acquir Immune Defic Syndr. 2007;46:656-657.
    PubMed     Related articles   


  115. BLADES R , Li K, Kerr T, Tyndall MW, et al
    Contribution of HIV to Mortality Among Injection Drug Users in the Era of HAART.
    J Acquir Immune Defic Syndr. 2007;46:655-656.
    PubMed     Related articles   


  116. KANTARCI S , Koulinska IN, Aboud S, Fawzi WW, et al
    Subclinical Mastitis, Cell-Associated HIV-1 Shedding in Breast Milk, and Breast-Feeding Transmission of HIV-1.
    J Acquir Immune Defic Syndr. 2007;46:651-654.
    PubMed     Related articles    Abstract available


  117. MILLETT GA , Ding H, Lauby J, Flores S, et al
    Circumcision Status and HIV Infection Among Black and Latino Men Who Have Sex With Men in 3 US Cities.
    J Acquir Immune Defic Syndr. 2007;46:643-650.
    PubMed     Related articles    Abstract available


  118. WATSON-JONES D , Weiss HA, Rusizoka M, Baisley K, et al
    Risk Factors for Herpes Simplex Virus Type 2 and HIV Among Women at High Risk in Northwestern Tanzania: Preparing for an HSV-2 Intervention Trial.
    J Acquir Immune Defic Syndr. 2007;46:631-642.
    PubMed     Related articles    Abstract available


  119. BEBELL LM , Gasasira A, Kiggundu M, Dokomajilar C, et al
    HIV-1 Infection in Patients Referred for Malaria Blood Smears at Government Health Clinics in Uganda.
    J Acquir Immune Defic Syndr. 2007;46:624-630.
    PubMed     Related articles    Abstract available


  120. WAMBURA M , Urassa M, Isingo R, Ndege M, et al
    HIV Prevalence and Incidence in Rural Tanzania: Results From 10 Years of Follow-Up in an Open-Cohort Study.
    J Acquir Immune Defic Syndr. 2007;46:616-623.
    PubMed     Related articles    Abstract available



  121. Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients.
    J Acquir Immune Defic Syndr. 2007;46:607-15.
    PubMed     Related articles    Abstract available


  122. CHATTERJEE A , Bosch RJ, Hunter DJ, Fataki MR, et al
    Maternal Disease Stage and Child Undernutrition in Relation to Mortality Among Children Born to HIV-Infected Women in Tanzania.
    J Acquir Immune Defic Syndr. 2007;46:599-606.
    PubMed     Related articles    Abstract available


  123. SACCHI A , Cappelli G, Cairo C, Martino A, et al
    Differentiation of Monocytes Into CD1a- Dendritic Cells Correlates With Disease Progression in HIV-Infected Patients.
    J Acquir Immune Defic Syndr. 2007;46:519-528.
    PubMed     Related articles    Abstract available


  124. WATERS L , Kambugu A, Tibenderana H, Meya D, et al
    Evaluation of filter paper transfer of whole-blood and plasma samples for quantifying HIV RNA in subjects on antiretroviral therapy in Uganda.
    J Acquir Immune Defic Syndr. 2007;46:590-3.
    PubMed     Related articles    Abstract available


  125. CAREY DL , Baker D, Rogers GD, Petoumenos K, et al
    A randomized, multicenter, open-label study of poly-L-lactic acid for HIV-1 facial lipoatrophy.
    J Acquir Immune Defic Syndr. 2007;46:581-9.
    PubMed     Related articles    Abstract available


  126. JOHNSON MO , Charlebois E, Morin SF, Remien RH, et al
    Effects of a behavioral intervention on antiretroviral medication adherence among people living with HIV: the healthy living project randomized controlled study.
    J Acquir Immune Defic Syndr. 2007;46:574-80.
    PubMed     Related articles    Abstract available


  127. STEBBINS GT , Smith CA, Bartt RE, Kessler HA, et al
    HIV-associated alterations in normal-appearing white matter: a voxel-wise diffusion tensor imaging study.
    J Acquir Immune Defic Syndr. 2007;46:564-73.
    PubMed     Related articles    Abstract available


  128. MARU DS , Kozal MJ, Bruce RD, Springer SA, et al
    Directly administered antiretroviral therapy for HIV-infected drug users does not have an impact on antiretroviral resistance: results from a randomized controlled trial.
    J Acquir Immune Defic Syndr. 2007;46:555-63.
    PubMed     Related articles    Abstract available


  129. SCHACKMAN BR , Ribaudo HJ, Krambrink A, Hughes V, et al
    Racial differences in virologic failure associated with adherence and quality of life on efavirenz-containing regimens for initial HIV therapy: results of ACTG A5095.
    J Acquir Immune Defic Syndr. 2007;46:547-54.
    PubMed     Related articles    Abstract available


  130. VAN DE WIJGERT JH , Braunstein SL, Morar NS, Jones HE, et al
    Carraguard Vaginal Gel Safety in HIV-Positive Women and Men in South Africa.
    J Acquir Immune Defic Syndr. 2007;46:538-46.
    PubMed     Related articles    Abstract available


  131. MOZOS A , Garrido M, Carreras J, Plana M, et al
    Redistribution of FOXP3-positive regulatory T cells from lymphoid tissues to peripheral blood in HIV-infected patients.
    J Acquir Immune Defic Syndr. 2007;46:529-37.
    PubMed     Related articles    Abstract available


  132. TORNERO C , Santamaria A, Gil E
    The presence of a caregiving relative implicated in the administration of antiretroviral drug administration improves virologic response.
    J Acquir Immune Defic Syndr. 2007;46:658.
    PubMed     Related articles   


  133. ZHANG F , Haberer JE, Zhao Y, Dou Z, et al
    Chinese pediatric highly active antiretroviral therapy observational cohort: a 1-year analysis of clinical, immunologic, and virologic outcomes.
    J Acquir Immune Defic Syndr. 2007;46:594-8.
    PubMed     Related articles    Abstract available


  134. KUHN L , Thea DM, Aldrovandi GM
    Bystander effects: children who escape infection but not harm.
    J Acquir Immune Defic Syndr. 2007;46:517-8.
    PubMed     Related articles   


  135. HORBERG MA , Silverberg MJ, Hurley LB, Towner WJ, et al
    Effects of Depression and Selective Serotonin Reuptake Inhibitor Use on Adherence to Highly Active Antiretroviral Therapy and on Clinical Outcomes in HIV-Infected Patients.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  136. TEBAS P , Bellos N, Lucasti C, Richmond G, et al
    Enfuvirtide Does Not Require Dose Adjustment in Patients With Chronic Kidney Failure: Results of a Pharmacokinetic Study of Enfuvirtide in HIV-1-Infected Patients With Impaired Kidney Function.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  137. SRITHANAVIBOONCHAI K , Rungruengthanakit K, Nouanthong P, Pata S, et al
    Novel Low-Cost Assay for the Monitoring of CD4 Counts in HIV-Infected Individuals.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  138. BANSIL P , Jamieson DJ, Posner SF, Johnson CH, et al
    Trends in Pregnancy-Related and Delivery Hospitalizations Among HIV-Infected Adolescents, 1994 to 2004.
    J Acquir Immune Defic Syndr. 2007;46:514-515.
    PubMed     Related articles   


  139. BISCIONE FM
    Regarding "Persistence of Neuropsychologic Deficits Despite Long-Term Highly Active Antiretroviral Therapy in Patients With HIV-Related Neurocognitive Impairment: Prevalence and Risk Factors".
    J Acquir Immune Defic Syndr. 2007;46:510.
    PubMed     Related articles   


  140. TOZZI V , Balestra P, Salvatori MF
    Authors' Response to Biscione: "Estimating the Risk of Persistent Neuropsychologic Deficits Despite Long-Term Highly Active Antiretroviral Therapy in Patients With HIV-Related Neurocognitive Impairment".
    J Acquir Immune Defic Syndr. 2007;46:510-2.
    PubMed     Related articles   


  141. ROCHA CM , Machado DM, Sucupira MC, Succi RC, et al
    Cerebrospinal Fluid Viral Load Quantification in an HIV-1-Infected Pediatric Group.
    J Acquir Immune Defic Syndr. 2007;46:508-509.
    PubMed     Related articles   


  142. GORRY PR , Churchill M, Learmont J, Cherry C, et al
    Replication-Dependent Pathogenicity of Attenuated nef-Deleted HIV-1 In Vivo.
    J Acquir Immune Defic Syndr. 2007;46:390-394.
    PubMed     Related articles    Abstract available


  143. ROTHERAM-BORUS MJ , Klosinski LE, Etzel MA
    Differences Between Proof-of-Concept Studies and Effective Implementation: Routine, Opt-Out HIV Testing in Emergency Departments.
    J Acquir Immune Defic Syndr. 2007;46:381-3.
    PubMed     Related articles   


  144. MIRANDA M , Chacon MR, Vidal F, Megia A, et al
    LMNA messenger RNA expression in highly active antiretroviral therapy-treated HIV-positive patients.
    J Acquir Immune Defic Syndr. 2007;46:384-9.
    PubMed     Related articles    Abstract available


  145. MCDERMID JM , Jaye A, Schim van der Loeff MF, Todd J, et al
    Elevated iron status strongly predicts mortality in West African adults with HIV infection.
    J Acquir Immune Defic Syndr. 2007;46:498-507.
    PubMed     Related articles    Abstract available


  146. GO VF , Solomon S, Srikrishnan AK, Sivaram S, et al
    HIV rates and risk behaviors are low in the general population of men in Southern India but high in alcohol venues: results from 2 probability surveys.
    J Acquir Immune Defic Syndr. 2007;46:491-7.
    PubMed     Related articles    Abstract available


  147. LIEB S , Trepka MJ, Thompson DR, Arons P, et al
    Men who have sex with men: estimated population sizes and mortality rates by race/ethnicity, Miami-Dade County, Florida.
    J Acquir Immune Defic Syndr. 2007;46:485-90.
    PubMed     Related articles    Abstract available


  148. CHUNG MH , Kiarie JN, Richardson BA, Lehman DA, et al
    Independent effects of nevirapine prophylaxis and HIV-1 RNA suppression in breast milk on early perinatal HIV-1 transmission.
    J Acquir Immune Defic Syndr. 2007;46:472-8.
    PubMed     Related articles    Abstract available


  149. AHRENS K , Kent CK, Kohn RP, Nieri G, et al
    HIV partner notification outcomes for HIV-infected patients by duration of infection, San Francisco, 2004 to 2006.
    J Acquir Immune Defic Syndr. 2007;46:479-84.
    PubMed     Related articles    Abstract available


  150. WOLF LL , Ricketts P, Freedberg KA, Williams-Roberts H, et al
    The cost-effectiveness of antiretroviral therapy for treating HIV disease in the Caribbean.
    J Acquir Immune Defic Syndr. 2007;46:463-71.
    PubMed     Related articles    Abstract available


  151. MANABE YC , Campbell JD, Sydnor E, Moore RD, et al
    Immune reconstitution inflammatory syndrome: risk factors and treatment implications.
    J Acquir Immune Defic Syndr. 2007;46:456-62.
    PubMed     Related articles    Abstract available


  152. MUTIMURA E , Stewart A, Rheeder P, Crowther NJ, et al
    Metabolic function and the prevalence of lipodystrophy in a population of HIV-infected african subjects receiving highly active antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2007;46:451-5.
    PubMed     Related articles    Abstract available


  153. PARSONS JT , Golub SA, Rosof E, Holder C, et al
    Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial.
    J Acquir Immune Defic Syndr. 2007;46:443-50.
    PubMed     Related articles    Abstract available


  154. REYNOLDS NR , Sun J, Nagaraja HN, Gifford AL, et al
    Optimizing measurement of self-reported adherence with the ACTG Adherence Questionnaire: a cross-protocol analysis.
    J Acquir Immune Defic Syndr. 2007;46:402-9.
    PubMed     Related articles    Abstract available


  155. BROWN J , Shesser R, Simon G, Bahn M, et al
    Routine HIV screening in the emergency department using the new US Centers for Disease Control and Prevention Guidelines: results from a high-prevalence area.
    J Acquir Immune Defic Syndr. 2007;46:395-401.
    PubMed     Related articles    Abstract available


  156. GESKUS R
    Censoring strategies when using competing risks with time-dependent covariates.
    J Acquir Immune Defic Syndr. 2007;46:512.
    PubMed     Related articles   


    November 2007
  157. BOLLEN LJ , Blanchard K, Kilmarx PH, Chaikummao S, et al
    No Increase in Cervicovaginal Proinflammatory Cytokines After Carraguard Use in a Placebo-Controlled Randomized Clinical Trial.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  158. KEMPF MC , Allen S, Zulu I, Kancheya N, et al
    Enrollment and Retention of HIV Discordant Couples in Lusaka, Zambia.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  159. CHOMBA E , Allen S, Kanweka W, Tichacek A, et al
    Evolution of Couples' Voluntary Counseling and Testing for HIV in Lusaka, Zambia.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  160. RAMJEE G , Kapiga S, Weiss S, Peterson L, et al
    The Value of Site Preparedness Studies for Future Implementation of Phase 2/IIb/III HIV Prevention Trials: Experience From the HPTN 055 Study.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  161. JASPAN HB , Cunningham CK, Tucker TJ, Wright PF, et al
    Inclusion of Adolescents in Preventive HIV Vaccine Trials: Public Health Policy and Research Design at a Crossroads.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  162. SMIT C , van den Berg C, Geskus R, Berkhout B, et al
    Risk of Hepatitis-Related Mortality Increased Among Hepatitis C Virus/HIV-Coinfected Drug Users Compared With Drug Users Infected Only With Hepatitis C Virus: A 20-Year Prospective Study.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  163. POTTER D , Goldenberg RL, Chao A, Sinkala M, et al
    Do Targeted HIV Programs Improve Overall Care for Pregnant Women?: Antenatal Syphilis Management in Zambia Before and After Implementation of Prevention of Mother-to-Child HIV Transmission Programs.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  164. RAHANGDALE L , Sarnquist C, Feakins C, Nassos P, et al
    Rapid HIV Testing on Labor and Delivery: Lessons From the Field.
    J Acquir Immune Defic Syndr. 2007;46:376-378.
    PubMed     Related articles   


  165. CARBONE J
    Immune Activation and Increased Prevalence of Thrombosis in HIV Infection.
    J Acquir Immune Defic Syndr. 2007;46:375-6.
    PubMed     Related articles   


  166. RUSCONI S , Gianotti N, Adorni F, Boeri E, et al
    Determinants of HIV-1 Genotypic Resistance to Darunavir (TMC114) in a Large Italian Resistance Database (Antiretroviral Resistance Cohort Analysis).
    J Acquir Immune Defic Syndr. 2007;46:373-375.
    PubMed     Related articles   


  167. KANG M , Chung RT
    The Role of Early Viral Decline in the Treatment of Hepatitis C in HIV-1-Coinfected Persons.
    J Acquir Immune Defic Syndr. 2007;46:371-373.
    PubMed     Related articles   


  168. WATERA C , Todd J, Mutonyi G, Miiro G, et al
    Effects of Cotrimoxazole on Hematologic Parameters in HIV-Infected Adults in a Community-Based Clinic in Entebbe, Uganda.
    J Acquir Immune Defic Syndr. 2007;46:369-71.
    PubMed     Related articles   



  169. HIV diagnosis at CD4 count above 500 cells/mm3 and progression to below 350 cells/mm3 without antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2007;46:275-8.
    PubMed     Related articles    Abstract available


  170. LARROUSSE M , Laguno M, Segarra M, De Lazzari E, et al
    Noninvasive diagnosis of hepatic fibrosis in HIV/HCV-coinfected patients.
    J Acquir Immune Defic Syndr. 2007;46:304-11.
    PubMed     Related articles    Abstract available


  171. BRUNO R , Sacchi P, Puoti M, Maiocchi L, et al
    Natural history of compensated viral cirrhosis in a cohort of patients with HIV infection.
    J Acquir Immune Defic Syndr. 2007;46:297-303.
    PubMed     Related articles    Abstract available


  172. JONES TS , Vlahov D
    What we can learn from the INSPIRE Study about improving prevention and clinical care for injection drug users living with HIV.
    J Acquir Immune Defic Syndr. 2007;46 Suppl 2:S31-4.
    PubMed     Related articles   


  173. MCCONNELL M , Bakaki P, Eure C, Mubiru M, et al
    Effectiveness of repeat single-dose nevirapine for prevention of mother-to-child transmission of HIV-1 in repeat pregnancies in Uganda.
    J Acquir Immune Defic Syndr. 2007;46:291-6.
    PubMed     Related articles    Abstract available


  174. GRUNFELD C , Rimland D, Gibert CL, Powderly WG, et al
    Association of upper trunk and visceral adipose tissue volume with insulin resistance in control and HIV-infected subjects in the FRAM study.
    J Acquir Immune Defic Syndr. 2007;46:283-90.
    PubMed     Related articles    Abstract available


  175. SHELDON J , Ramos B, Garcia-Samaniego J, Rios P, et al
    Selection of hepatitis B virus (HBV) vaccine escape mutants in HBV-infected and HBV/HIV-coinfected patients failing antiretroviral drugs with anti-HBV activity.
    J Acquir Immune Defic Syndr. 2007;46:279-82.
    PubMed     Related articles    Abstract available


  176. RYCHERT J , Saindon S, Placek S, Daskalakis D, et al
    Sequence variation occurs in CD4 epitopes during early HIV infection.
    J Acquir Immune Defic Syndr. 2007;46:261-7.
    PubMed     Related articles    Abstract available


  177. VALVERDE EE , Purcell DW, Waldrop-Valverde D, Malow R, et al
    Correlates of depression among HIV-positive women and men who inject drugs.
    J Acquir Immune Defic Syndr. 2007;46 Suppl 2:S96-100.
    PubMed     Related articles    Abstract available


  178. LATKA MH , Mizuno Y, Wu Y, Tobin KE, et al
    Are feelings of responsibility to limit the sexual transmission of HIV associated with safer sex among HIV-positive injection drug users?
    J Acquir Immune Defic Syndr. 2007;46 Suppl 2:S88-95.
    PubMed     Related articles    Abstract available


  179. KNIGHT KR , Shade SB, Purcell DW, Rose CD, et al
    Sexual transmission risk behavior reported among behaviorally bisexual HIV-positive injection drug-using men.
    J Acquir Immune Defic Syndr. 2007;46 Suppl 2:S80-7.
    PubMed     Related articles    Abstract available


  180. METSCH LR , Pereyra M, Purcell DW, Latkin CA, et al
    Correlates of lending needles/syringes among HIV-seropositive injection drug users.
    J Acquir Immune Defic Syndr. 2007;46 Suppl 2:S72-9.
    PubMed     Related articles    Abstract available


  181. ARNSTEN JH , Li X, Mizuno Y, Knowlton AR, et al
    Factors associated with antiretroviral therapy adherence and medication errors among HIV-infected injection drug users.
    J Acquir Immune Defic Syndr. 2007;46 Suppl 2:S64-71.
    PubMed     Related articles    Abstract available


  182. MITCHELL SG , Edwards LV, Mackenzie S, Knowlton AR, et al
    Participants' descriptions of social support within a multisite intervention for HIV-seropositive injection drug users (INSPIRE).
    J Acquir Immune Defic Syndr. 2007;46 Suppl 2:S55-63.
    PubMed     Related articles    Abstract available


  183. MIZUNO Y , Purcell DW, Mackenzie S, Tobin KE, et al
    Acceptability of A-CASI by HIV-positive IDUs in a multisite, randomized, controlled trial of behavioral intervention (INSPIRE).
    J Acquir Immune Defic Syndr. 2007;46 Suppl 2:S48-54.
    PubMed     Related articles    Abstract available


  184. PURCELL DW , Latka MH, Metsch LR, Latkin CA, et al
    Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users.
    J Acquir Immune Defic Syndr. 2007;46 Suppl 2:S35-47.
    PubMed     Related articles    Abstract available


  185. WILKINSON JD , Zhao W, Arnsten JH, Knowlton AR, et al
    Longitudinal correlates of health care-seeking behaviors among HIV-seropositive injection drug users: how can we intervene to improve health care utilization?
    J Acquir Immune Defic Syndr. 2007;46 Suppl 2:S120-6.
    PubMed     Related articles    Abstract available


  186. KNOWLTON AR , Arnsten JH, Gourevitch MN, Eldred L, et al
    Microsocial environmental influences on highly active antiretroviral therapy outcomes among active injection drug users: the role of informal caregiving and household factors.
    J Acquir Immune Defic Syndr. 2007;46 Suppl 2:S110-9.
    PubMed     Related articles    Abstract available


  187. FRYE V , Latka MH, Wu Y, Valverde EE, et al
    Intimate partner violence perpetration against main female partners among HIV-positive male injection drug users.
    J Acquir Immune Defic Syndr. 2007;46 Suppl 2:S101-9.
    PubMed     Related articles    Abstract available


  188. VOETSCH AC , Heffelfinger JD, Begley EB, Jafa-Bhushan K, et al
    Knowledge and use of preexposure and postexposure prophylaxis among attendees of Minority Gay Pride events, 2005 through 2006.
    J Acquir Immune Defic Syndr. 2007;46:378-80.
    PubMed     Related articles   


  189. WESTER CW , Okezie OA, Thomas AM, Bussmann H, et al
    Higher-than-expected rates of lactic acidosis among highly active antiretroviral therapy-treated women in Botswana: preliminary results from a large randomized clinical trial.
    J Acquir Immune Defic Syndr. 2007;46:318-22.
    PubMed     Related articles    Abstract available


    October 2007
  190. SELINGER-LENEMAN H , Matheron S, Mahamat A, Moreau J, et al
    Dual Nucleoside Reverse Transcriptase Inhibitor Therapy in the Combination Antiretroviral Therapy Era and Predictors of Discontinuation or Switch to Combination Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  191. BURMAN W , Grund B, Roediger MP, Friedland G, et al
    The Impact of Episodic CD4 Cell Count-Guided Antiretroviral Therapy on Quality of Life.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  192. ARRIBAS JR , Pozniak AL, Gallant JE, Dejesus E, et al
    Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Compared With Zidovudine/Lamivudine and Efavirenz in Treatment-Naive Patients: 144-Week Analysis.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  193. MALAN DR , Krantz E, David N, Wirtz V, et al
    Efficacy and Safety of Atazanavir, With or Without Ritonavir,as Part of Once-Daily Highly Active Antiretroviral Therapy Regimens in Antiretroviral-Naive Patients.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  194. PENCE BW , Ostermann J, Kumar V, Whetten K, et al
    The Influence of Psychosocial Characteristics and Race/Ethnicity on the Use, Duration, and Success of Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  195. YILMAZ A , Price RW, Spudich S, Fuchs D, et al
    Persistent Intrathecal Immune Activation in HIV-1-Infected Individuals on Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  196. JOY T , Keogh HM, Hadigan C, Dolan SE, et al
    Relation of Body Composition to Body Mass Index in HIV-Infected Patients With Metabolic Abnormalities.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  197. PORTER K , Walker S, Hill T, Anderson J, et al
    Changes in Outcome of Persons Initiating Highly Active Antiretroviral Therapy at a CD4 Count Less Than 50 Cells/mm3.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  198. DALAL RP , Macphail C, Mqhayi M, Wing J, et al
    Characteristics and Outcomes of Adult Patients Lost to Follow-Up at an Antiretroviral Treatment Clinic in Johannesburg, South Africa.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  199. GERBER JG , Kitch DW, Fichtenbaum CJ, Zackin RA, et al
    Fish Oil and Fenofibrate for the Treatment of Hypertriglyceridemia in HIV-Infected Subjects on Antiretroviral Therapy: Results of ACTG A5186.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  200. DANIEL V , Naujokat C, Sadeghi M, Zimmermann R, et al
    Normal or Even Increased Dendritic Cell and Peripheral Blood Lymphocyte Subsets With Regulatory Phenotype in Clinically Stable Long-Term HIV-Infected Patients With Hemophilia on Highly Active Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  201. MIRANDA M , Chacon MR, Vidal F, Megia A, et al
    LMNA Messenger RNA Expression in Highly Active Antiretroviral Therapy-Treated HIV-Positive Patients.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  202. VALERIO L , Yazdanpanah Y, Poizot-Martin I, Rosenthal E, et al
    Baseline CD4 Cell Count and Outcome of Pegylated Interferon Plus Ribavirin Therapy in HIV/Hepatitis C Virus-Coinfected Patients.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  203. MCDERMID JM , Jaye A, van der Loeff MF, Todd J, et al
    Elevated Iron Status Strongly Predicts Mortality in West African Adults With HIV Infection.
    J Acquir Immune Defic Syndr. 2007;.
    PubMed     Related articles    Abstract available


  204. MILAZZO L , Menzaghi B, Corvasce S, Bonfanti P, et al
    Safety of Statin Therapy in HIV/Hepatitis C Virus-Coinfected Patients.
    J Acquir Immune Defic Syndr. 2007;46:258-260.
    PubMed     Related arti